MSX-127

Details:

Shanghai Hope-Chem Co.,Ltd is high-tech company integrated with the R&D, production and marketing. It was establish in 2014. The main products are APIs and intermediates of antiviral drug substances and anti-inflammatory, analgesic, non-steroidal pharmaceuticals.

Indrastructure& Facility:
Our GMP plant covers about 43,000.m2, the total employee is about 560, more than 42% of personnel have the college above education background, more than 160 people are engineer and technicians. The total asset is about RMB806 million. The products, more than 80%, are exported to overseas including Europe, USA, Asia and twenty other countries.
In March 2015, the Group established a R&D company in New York which specialized in in-America new drug development, FDA registration and market channel connecting. The company has submitted drug registration application to FDA.

Research and Development:
The GMP plant prides itself for being an organizations that thrives on a robust research and development program. We have started investing in R&D in the very beginning of establishment, which gave us a head start for developing an expansive basket of products to meet diverse market requirements across the globe.Also, our extensive focus on R&D helped us transcend API research to successfully expand our capabilities into the realm of API’s and Pharmaceutical Intermediates. In fact, research is a mainstay of our business goals.
Our creative and experienced process chemists are dedicated to design and develop synthetic processes that are experimentally friendly and economically viable.

Quality Control:
A well-equipped advanced lab for quality testing according to the pre-determined MOA as per pharmacopoeia or in-house developed and validated analytical methods, we preform the analysis in compliance with the ICH guidelines.

Quality Assurance:
The GMP plant aim at achieving a high degree of quality in our products and services.
Our vision is to achieve international standards of quality, through persistent hard work and better impleme